{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T23:56:18Z","timestamp":1720310178467},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taipei City Hospital, Taipei, Taiwan"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.etap.2016.05.021","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T23:42:47Z","timestamp":1464133367000},"page":"108-114","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Shift from darbepoetin-\u03b1 to continuous erythropoietin receptor activator decreases serum aluminium concentration in patients on hemodialysis"],"prefix":"10.1016","volume":"45","author":[{"given":"Wen-Sheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiang-Lin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Ting","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hsu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Wei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Kuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2016.05.021_bib0005","doi-asserted-by":"crossref","unstructured":"Bover, J. Urena, P., Brandenburg, V., Goldsmith, D., Ruiz, C., Da Silva, I., Bosch, R.J., 2014. Adynamic bone disease: from bone to vessels in chronic kidney disease Semin Nephrol 34, 626\u2013640.","DOI":"10.1016\/j.semnephrol.2014.09.008"},{"key":"10.1016\/j.etap.2016.05.021_bib0010","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000169658","article-title":"Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects","volume":"29","author":"Chiang","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.etap.2016.05.021_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000350151","article-title":"Effect of conversion from ESA with shorter half-life to CERA once monthly for maintaining Hb concentration in pre-dialysis CKD patients","volume":"37","author":"Choi","year":"2013","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.etap.2016.05.021_bib0020","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ndt\/16.4.742","article-title":"Effect of aluminium load on parathyroid hormone synthesis","volume":"16","author":"Diaz-Corte","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.etap.2016.05.021_bib0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1258\/0004563053492757","article-title":"In end-stage renal failure, does infection lead to elevated plasma aluminium and neurotoxicity? Implications for monitoring","volume":"42","author":"Fenwick","year":"2005","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.etap.2016.05.021_bib0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2369-14-157","article-title":"Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A: a randomized controlled trial","volume":"14","author":"Forni","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.etap.2016.05.021_bib0035","first-page":"27","article-title":"Influence of aluminium on erythropoiesis, iron metabolism and some functional characteristics of erythrocytes in rats","volume":"23","author":"Ganchev","year":"1998","journal-title":"Acta Physiol. Pharmacol. Bulg."},{"key":"10.1016\/j.etap.2016.05.021_bib0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.jrn.2004.01.005","article-title":"Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients","volume":"14","author":"Kalantar-Zadeh","year":"2004","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.etap.2016.05.021_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000245041","article-title":"Erythropoiesis stimulatory agent-resistant anemia in dialysis patients: review of causes and management","volume":"29","author":"Kanbay","year":"2010","journal-title":"Blood Purif."},{"key":"10.1016\/j.etap.2016.05.021_bib0050","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/10715760500306968","article-title":"Aluminum ions stimulate the oxidizability of low density lipoprotein by Fe2+: implication in hemodialysis mediated atherogenic LDL modification","volume":"39","author":"Kapiotis","year":"2005","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.etap.2016.05.021_bib0055","first-page":"396","article-title":"Association between serum levels of Hs-CRP and LDL-C with degree of Coronary artery stenosis in patients with stable angina pectoris","volume":"12","author":"Kojuri","year":"2010","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.etap.2016.05.021_bib0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/08860229909094160","article-title":"Low dose desferrioxamine can improve erythropoiesis in iron-overload hemodialysis patients without side effects","volume":"21","author":"Lee","year":"1999","journal-title":"Ren. Fail."},{"key":"10.1016\/j.etap.2016.05.021_bib0065","doi-asserted-by":"crossref","first-page":"157437","DOI":"10.1100\/2012\/157437","article-title":"The waveform fluctuation and the clinical factors of the initial and sustained erythropoietic response to continuous erythropoietin receptor activator in hemodialysis patients","volume":"2012","author":"Liu","year":"2012","journal-title":"Sci. World J."},{"key":"10.1016\/j.etap.2016.05.021_bib0070","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood.V93.10.3286.410k29_3286_3293","article-title":"The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply","volume":"93","author":"Loo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.etap.2016.05.021_bib0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1537-2995.2004.00653.x","article-title":"Transfusions via hand-held syringes and small-gauge needles as risk factors for hyperkalemia","volume":"44","author":"Miller","year":"2004","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.etap.2016.05.021_bib0080","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1080\/10428190902878430","article-title":"Serum erythropoietin at diagnosis in low grade myelodysplastic syndrome correlates with both red cell zinc protoporphyrin and serum lactic dehydrogenase (LDH) and may reflect severity of ineffective erythropoiesis","volume":"50","author":"Murphy","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.etap.2016.05.021_bib0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nephro.2009.10.004","article-title":"Direct medical cost of erythropoiesis-stimulating agents in anaemia treatment of chronic renal failure patient: a literature review","volume":"6","author":"Ranchon","year":"2010","journal-title":"Nephrol. Ther."},{"key":"10.1016\/j.etap.2016.05.021_bib0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.20804","article-title":"Hypocholesterolemia in chronic anemias with increased erythropoietic activity","volume":"82","author":"Shalev","year":"2007","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.etap.2016.05.021_bib0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00508-010-1409-y","article-title":"Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease","volume":"122","author":"Teplan","year":"2010","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.etap.2016.05.021_bib0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1517\/14656566.9.5.839","article-title":"CERA: third-generation erythropoiesis-stimulating agent","volume":"9","author":"Topf","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.etap.2016.05.021_bib0105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2015.11.030","article-title":"Recommendations for kidney disease guideline updating: a report by the KDIGO Methods Committee","volume":"89","author":"Uhlig","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.etap.2016.05.021_bib0110","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jinorgbio.2011.07.024","article-title":"Evidence for aluminum-binding erythropoietin by size-exclusion chromatography coupled to electrothermal absorption atomic spectrometry","volume":"105","author":"Veiga","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.etap.2016.05.021_bib0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0162-0134(99)00122-1","article-title":"Morphologic and functional alterations of erythroid cells induced by long-term ingestion of aluminium","volume":"76","author":"Vittori","year":"1999","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.etap.2016.05.021_bib0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/pgmj.69.808.124","article-title":"Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy","volume":"69","author":"Yaqoob","year":"1993","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.etap.2016.05.021_bib0125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1440-1797.2009.01184.x","article-title":"Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort","volume":"15","author":"Yong","year":"2010","journal-title":"Nephrology"}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668916301259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668916301259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T23:01:37Z","timestamp":1600642897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668916301259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":25,"alternative-id":["S1382668916301259"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2016.05.021","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shift from darbepoetin-\u03b1 to continuous erythropoietin receptor activator decreases serum aluminium concentration in patients on hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2016.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}